𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Distinct biological activities of recombinant forms of human interleukin-2 in vivo

✍ Scribed by A. B. Lentsch; Koji Nakagawa; Hiroyuki Yoshidome; Alexandra Gerassimides; Frederick N. Miller; Michael J. Edwards


Publisher
Springer-Verlag
Year
1997
Tongue
English
Weight
257 KB
Volume
43
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


In vivo anti-tumour activity of recombin
✍ Karim El Bakkouri; Charlotte Servais; Nathalie ClΓ©ment; Siew Chiat Cheong; Jean- πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 153 KB

## Background The natural oncotropism and oncotoxicity of vectors derived from the autonomous parvovirus, minute virus of mice (prototype strain) [MVM(p)], combined with the immunotherapeutic properties of cytokine transgenes, make them interesting candidates for cancer gene therapy. ## Methods

In vivo activation of lymphocytes in mel
✍ Carlo Gambacorti-Passerini; Marina Radrizzani; Raffaele Marolda; Filiberto Belli πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 705 KB

A phase-I study of the recombinant, non-mutagenized interleukin 2 (rlL2, Bioleukin'") was performed in 12 melanoma patients (Pts). From 100 to 800 pg/m2 of rlL2 were administered by i.v. bolus injection, TID for 4-8 days. Side-effects included fever, malaise, low serum K + and C a + + values, electr

Detection of distinct human immunodefici
✍ Luciane Amorim Santos; Joana Paixao Monteiro-Cunha; Adriano Fernando Araujo; Car πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 171 KB

## Abstract The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose significant challenges for vaccine development and antiretroviral therapy efficacy. The objective of this study was to characterize the molecular profile of HIV‐1 epidemic in Salvador, Bahi